Abstract
ABSTRACTMutations in genes encoding the human brain-expressed voltage-gated sodium (NaV) channels NaV1.1, NaV1.2, and NaV1.6 are associated with a variety of human diseases including epilepsy, autism spectrum disorder, familial migraine, and other neurodevelopmental disorders. A major obstacle hindering investigations of the functional consequences of brain NaV channel mutations is an unexplained instability of the corresponding recombinant complementary DNA (cDNA) when propagated in commonly used bacterial strains manifested by high spontaneous rates of mutation. Here we investigated the cause for instability of human NaV1.1 cDNA. We identified cryptic prokaryotic promoter-like elements that are presumed to drive transcription of translationally toxic mRNAs in bacteria as the cause of the instability, and demonstrated that mutations in these elements can mitigate the instability. Extending these observations, we generated full-length human NaV1.1, NaV1.2, and NaV1.6 plasmids using one or two introns that interrupt the cryptic reading frames along with a minimum number of silent nucleotide changes that achieved stable propagation in bacteria. Expression of the stabilized sequences in cultured mammalian cells resulted in functional NaV channels with properties that matched their parental constructs. Our findings explain a widely observed instability of recombinant neuronal human NaV channels, and we describe re-engineered plasmids that attenuate this problem.
Publisher
Cold Spring Harbor Laboratory
Reference21 articles.
1. Decaen, P. G. , George, A. L., Jr. , and Thompson, C. H. (2019) Sodium channelopathies of the central nervous system. in The Oxford Handbook of Neuronal Ion Channels ( Bhattacharjee, A. ed.), Oxford University Press, Oxford, England. pp 1–36
2. Sodium Channels, Inherited Epilepsy, and Antiepileptic Drugs
3. The NaV channel bench series: Plasmid preparation;MethodsX.,2014
4. Gain of function of sporadic/familial hemiplegic migraine-causing SCN1A mutations: Use of an optimized cDNA;Cephalalgia,2019
5. Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol